货号:A805736
同义名:
弗拉西汀
/ 7,8-Dihydroxy-6-Methoxycoumarin
Fraxetin是从白蜡树中提取的天然产物,具有抗肿瘤、抗菌、抗氧化和抗炎作用,并可通过诱导细胞凋亡抵抗细胞毒性,是保护神经和细胞健康的重要分子。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Fraxetin, a natural product isolated and purified from the bark of Fraxinus brngeana DC., has protective against rotenone-induced cytotoxicity, apoptotic death and antioxidant activities. |
| Concentration | Treated Time | Description | References | |
| Yeast microsomes | 100 μM fraxetin | 1 hour | Validate CYP82C4's ability to convert fraxetin to sideretin | Nat Chem Biol. 2018 May;14(5):442-450 |
| Patu8988 cells | 50 or 100 μM | 24 hours | To evaluate the effect of Fraxetin on the proliferation of Patu8988 cells. Results showed that Fraxetin inhibited the proliferation of Patu8988 cells in a concentration-dependent manner. | Aging (Albany NY). 2021 Jul 28;13(14):18545-18563 |
| PANC-1 cells | 50 or 100 μM | 24 hours | To evaluate the effect of Fraxetin on the proliferation of PANC-1 cells. Results showed that Fraxetin inhibited the proliferation of PANC-1 cells in a concentration-dependent manner. | Aging (Albany NY). 2021 Jul 28;13(14):18545-18563 |
| prostate cancer cell DU145 | 10, 20, 40 μM | 48 hours | To evaluate the effect of Fraxetin on cell migration and invasion, results showed that Fraxetin significantly inhibited DU145 cell migration and invasion | Bioengineered. 2022 Apr;13(4):9345-9356 |
| prostate cancer cell DU145 | 10, 20, 40 μM | 48 hours | To evaluate the effect of Fraxetin on cell apoptosis, results showed that Fraxetin significantly increased the ratio of apoptotic DU145 cells | Bioengineered. 2022 Apr;13(4):9345-9356 |
| prostate cancer cell DU145 | 10, 20, 40 μM | 24, 48, 72 hours | To evaluate the effect of Fraxetin on cell proliferation, results showed that Fraxetin significantly inhibited DU145 cell proliferation | Bioengineered. 2022 Apr;13(4):9345-9356 |
| prostate cancer cell DU145 | 10, 20, 40, 80 μM | 48 hours | To evaluate the effect of Fraxetin on cell viability, results showed that Fraxetin significantly reduced DU145 cell viability | Bioengineered. 2022 Apr;13(4):9345-9356 |
| prostatic epithelial cell RWPE-1 | 10, 20, 40, 80 μM | 48 hours | To evaluate the effect of Fraxetin on cell viability, results showed that Fraxetin had no obvious effect on RWPE-1 cell viability | Bioengineered. 2022 Apr;13(4):9345-9356 |
| HL-60 cells | 0, 20, 40, 80, 160 µM | 24, 48, 72 hours | To evaluate the inhibitory effect of Fraxetin on the proliferation of HL-60 cells. The results showed that the viability of HL-60 cells was inhibited at different time points as the concentration of fraxetin increased. | BMC Complement Med Ther. 2024 Jun 10;24(1):226 |
| THP-1 cells | 0, 20, 40, 80, 160 µM | 24, 48, 72 hours | To evaluate the inhibitory effect of Fraxetin on the proliferation of THP-1 cells. The results showed that the viability of THP-1 cells was inhibited at different time points as the concentration of fraxetin increased. | BMC Complement Med Ther. 2024 Jun 10;24(1):226 |
| 3T3-L1 cells | 0, 5, 10, 20, 50, 100 µM | 2 days | To evaluate the effect of Fraxetin on adipogenesis and lipid accumulation. Results showed that Fraxetin significantly inhibited lipid droplet accumulation in 3T3-L1 cells without cytotoxicity. | Antioxidants (Basel). 2022 Sep 24;11(10):1893 |
| HL-60 cells | 40 µM, 80 µM, 120 µM | 48 hours | To evaluate the apoptotic effect of Fraxetin on HL-60 cells. The results showed that the apoptosis rate of HL-60 cells gradually increased with increasing concentrations of fraxetin. | BMC Complement Med Ther. 2024 Jun 10;24(1):226 |
| THP-1 cells | 50 µM, 100 µM, 150 µM | 48 hours | To evaluate the apoptotic effect of Fraxetin on THP-1 cells. The results showed that the apoptosis rate of THP-1 cells gradually increased with increasing concentrations of fraxetin. | BMC Complement Med Ther. 2024 Jun 10;24(1):226 |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice (BALB/c) | Pancreatic ductal adenocarcinoma (PDA) xenograft model | Intragastric administration | 25 mg/kg·d | Every 3 days for one month | To evaluate the effect of Fraxetin on tumor growth and metastasis in PDA xenograft models. Results showed that Fraxetin significantly inhibited tumor growth and metastasis. | Aging (Albany NY). 2021 Jul 28;13(14):18545-18563 |
| Arabidopsis thaliana | Fe-deficient Arabidopsis | Media supplementation | 120 μM fraxetin | 14 days | Partially rescued the s8h mutants, indicating that fraxetin is a bioactive compound participating in the acquisition of Fe from immobile sources. | Plant Physiol. 2018 May;177(1):194-207 |
| Arabidopsis thaliana | F6’h1, s8h, cyp82C4 mutants | Agar medium | 150 μM | 6-hour treatment, lasting 7 days | Validate the rescue effect of fraxetin and sideretin on iron deficiency phenotypes | Nat Chem Biol. 2018 May;14(5):442-450 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.80mL 0.96mL 0.48mL |
24.02mL 4.80mL 2.40mL |
48.04mL 9.61mL 4.80mL |
|
| CAS号 | 574-84-5 |
| 分子式 | C10H8O5 |
| 分子量 | 208.17 |
| SMILES Code | O=C1C=CC2=C(O1)C(O)=C(O)C(OC)=C2 |
| MDL No. | MFCD00006873 |
| 别名 | 弗拉西汀 ;7,8-Dihydroxy-6-Methoxycoumarin |
| 运输 | 蓝冰 |
| InChI Key | HAVWRBANWNTOJX-UHFFFAOYSA-N |
| Pubchem ID | 5273569 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(504.4 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1